Professor Anne-Louise Ponsonby
Professor Anne-Louise Ponsonby has extensive experience in the design, conduct, and analysis of population-based studies and trials. She is a co PI of a large birth cohort that generated knowledge, translated into action, that led to an 80% reduction in sudden infant death syndrome incidence in Australia, from 1.9 per 1,000 live births in 1990 […]
Professor Danielle Mazza
Professor Danielle Mazza is an internationally distinguished general practice clinician researcher and Head of the Department of General Practice at Monash University. Her research and leadership have been highly influential in reducing inequities in access and improving the quality of clinical care delivered in general practice in women’s sexual and reproductive health, preventive care, the […]
Professor Mandana Nikpour
Professor Mandana Nikpour, rheumatologist, epidemiologist and NHMRC Fellow at the University of Melbourne is a globally recognised researcher in connective tissue diseases, scleroderma and lupus. Her prize-winning multidisciplinary research has informed understanding of disease aetiology and led to development of outcome measures, screening tests, and clinical trials of novel therapies, shaping international practice guidelines. She […]
Professor Sant-Rayn Pasricha
Professor Sant-Rayn Pasricha is a haematologist, epidemiologist and molecular biologist who leads the world’s most preeminent research program on global health anaemia control, with a record of resolving key evidence gaps, making transformative scientific discoveries, and translating knowledge into policy at the highest international level through multiple WHO guidelines. He has first/ senior author publications […]
Professor Erica Wood
Professor Erica Wood is an international authority on blood transfusion and Australia’s leading expert in transfusion practice and research. She Heads Monash University’s Transfusion Research Unit and is consultant haematologist at Monash Health. Her research has generated knowledge to improve transfusion supportive care and built national research capacity benefitting patients, blood donors and the community. […]
Professor Andrew Wei
Professor Andrew Wei is an internationally recognised leader in the field of acute myeloid leukaemia (AML). He has led nationwide trial development in Australia for 14 years as the AML chair for the ALLG. His laboratory has made pre-clinical contributions to the clinical development of BH3-mimetics in AML culminating in the regulatory approval of venetoclax […]
Professor Shyamali Dharmage
Professor Shyamali Dharmage is a world-recognised leader in epidemiology of chronic lung diseases whose research has led to paradigm changes, generated a new field of research (‘pre-COPD’) and changed guidelines worldwide. Her recognition of excellence is evidenced by national/international advisory board invitations (e.g. Lancet Commissioner in COPD), invited presentations (>90) and multiple prestigious awards (e.g. […]
Professor Susan Walker
Professor Susan Walker is a Maternal Fetal Medicine specialist and clinical academic. She is Head of the Department of Obstetrics and Gynaecology, and co-Director of Mercy Perinatal. Her research focuses on improving the detection of fetal growth restriction-the single biggest risk factor for stillbirth. She also co-leads international clinical trials of medications to prevent and […]
Professor Ego Seeman
Professor Ego Seeman is recognised as a global leader in the field of bone health through a series of studies that have transformed our understanding of the pathogenesis and treatment of osteoporosis. His pioneering studies on bone growth in utero, and delineation of sex and racial differences in bone architecture during growth help explain the […]
Professor Michael Hofman
Nuclear medicine physician‐scientist Professor Michael Hofman has pioneered use of novel radioactive molecules that seek out cancer cells for both whole body imaging and also targeted treatment. These new practice changing technologies have been adopted globally including PSMA PET imaging and radioligand therapy, demonstrating greater accuracy than standard imaging, and better outcomes and quality‐of‐life compared […]
Professor Catriona Bradshaw
Professor Catriona Bradshaw is a clinician researcher whose research has led to paradigm shifts in the diagnosis, treatment and control of drug-resistant and refractory sexually transmitted infections. She described the emergence of antibiotic-resistance in Mycoplasma genitalium, and identified new drugs and resistance-guided strategies to improve cure and antibiotic stewardship, which has repeatedly changed guidelines in […]
Professor Jian Li
Professor Jian Li’s antimicrobial research, clinical translation and commercialisation have provided impactful solutions to combat life-threatening multidrug-resistant bacterial infections globally. Notably, his world-leading research has led to a novel antibiotic drug QPX9003 which was developed intelligently from proof-of-concept to Phase-I trials. Furthermore, his long-term polymyxin pharmacology research has significantly improved clinical practice worldwide. He is […]
Professor Sophia Zoungas
Professor Sophia Zoungas, Head of the School of Public Health and Preventive Medicine at Monash University, is a Clinical Endocrinologist recognised internationally for her role in advancing knowledge in the management of diabetes and its vascular complications. She leads Australia’s largest translational research program in diabetes care and benchmarking of diabetes services. Professor Zounga’s research […]
Professor Mark Stevenson
Professor Mark Stevenson is an internationally renowned epidemiologist whose research and advocacy have led to transport and public health policies that have reduced the global burden of injury. His landmark research associated with mobile phone use and the risk of car crash led to legislative change across five countries. Additionally, his research on young driver […]
Professor Ben Solomon
Professor Ben Solomon is a clinician-scientist whose clinical and translational research has identified new treatments, changed standards of care and improved outcomes for patients with lung cancer, the leading cause of cancer-related death. His work has resulted in regulatory approvals for first, second and third generation ALK TKIs, defining new and transformative standards of care […]
Professor Shanthakumar Rajaratnam
Professor Shantha Rajaratnam’s research has taken circadian neuroscience into new clinical approaches: melatonin agonist (to FDA approval), light therapy and digital applications. He has published more than 165 peer-reviewed papers and two edited books, and he has led the peak body for sleep health and medicine (Australasian Sleep Association). He currently leads the Sleep Health […]
Professor Eric Morand
Professor Eric Morand is an internationally renowned academic physician-scientist. His career has focused on integrating clinical and laboratory science to advance patient outcomes in lupus. Professor Morand founded a multinational consortium to design and validate new clinical endpoints, solving a decade-long impasse responsible for multiple failed trials. He led the breakthrough Phase 3 trial of […]
Professor Laura Mackay
Professor Laura Mackay is a Howard Hughes and Bill and Melinda Gates-funded International Scholar, Sylvia and Charles Viertel Senior Research Fellow, NHMRC Leadership Fellow and Dame Kate Campbell Fellow. She has is an internationally recognised expert in T cell immunity, contributing landmark papers that have defined how memory T cell responses are generated in body […]
Professor Emma Kowal
Professor Emma Kowal is a leading expert in the social, ethical and cultural implications of genomics in Aboriginal and Torres Strait Islander communities. As a result of her research, Indigenous genomics has developed as a recognised area of importance both within Indigenous health and within precision medicine. Professor Kowal’s work developing national frameworks for biospecimen […]
Professor Anne Kavanagh
Professor Anne Kavanagh is an epidemiologist and public health physician who has made substantial contributions to knowledge across three areas: cancer screening, health inequities and disability. Her research has had major impacts on policy, including in relation to mammographic screening, local government priorities to promote healthy behaviour and approaches to improving the health of people […]